{description}The estimated 170 million people infected with Hepatitis C virus (HCV) have been living with limited medical options.  There is no cure for HCV, and today’s therapies work in only about 40% of the patients. However, recent f ndings in Stanford’s Department of Microbiology and Immunology have opened the door to discovering a  possible new way to treat HCV.
Hepatitis C Virus
HCV is one of several different hepatitis viruses  that cause inf ammation of the liver. Other common hepatitis viruses include food and water-borne Hepatitis A, which does not typically cause a chronic infection, and blood-borne Hepatitis B, which causes chronic disease in 10% of those infected.  Vaccines are available for both Hepatitis A and B.  {/description}